EPIMMUNE INCORPORATED
EPIMMUNE INCORPORATED
Industry:
Manufacturing
Founded:
1997-01-01
Address:
San Diego, California, United States
Country:
United States
Status:
Active
More informations about "Epimmune Incorporated"
Epimmune Company Profile 2024: Valuation, Investors ... - PitchBook
Epimmune is headquartered in San Diego, CA. What industry is Epimmune in? Epimmune’s primary industry is Biotechnology. Is Epimmune a private or public company? Epimmune is a …See details»
Epimmune, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Epimmune, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 2 news, and 25 literature, Drug:CY-1503, CY-1787, CY-725, CY ...See details»
Epimmune Inc Overview | SignalHire Company Profile
Epimmune Inc is a biotechnology company based out of 5820 Nancy Ridge Dr, San Diego, California, United States. ... Organization Website. epimmune.com . Epimmune Inc industries. …See details»
Epimmune Inc. - SEC.gov
Epimmune Inc. (Exact name of registrant as specified in its charter) Delaware : 33-0245076 (State or other jurisdiction of incorporation or organization) ... The World Health Organization (WHO) …See details»
Epimmune, IDM Merging To Build Immunotherapy Force
Mar 17, 2005 The new company, IDM Inc., will be located at Epimmune's headquarters in San Diego, with manufacturing sites in Irvine, Calif., and Paris. The goal is to create a leading …See details»
EPIMMUNE INC, San Diego CA - Company Profile | BizStanding
On any company or organization. Login; Business Contacts & Backgrounds. Search. CA; EP; EP-204; EPIMMUNE INC; EPIMMUNE INC. San Diego, CA. Background Check. Company …See details»
Epimmune Inc. - VentureRadar
Epimmune Inc. VentureRadar profile. Find out more about Epimmune Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more. ... Ardena …See details»
Epimmune Inc: Contact Details and Business Profile
The NAICS codes for Epimmune Inc are [325, 32541, 32, 3254]. What is the SIC code for Epimmune Inc? The SIC codes for Epimmune Inc are [283, 2834, 28]. Related Companies …See details»
Epimmune Inc. Information - CareersInPharmaceutical.com
Epimmune Inc., is located at San Diego, CA and is a biopharmaceutical company focused on the development of innovative products that activate the immune system to treat cancer. Our …See details»
IDM Pharma acquires Epimmune Incorporated - Crunchbase
Mar 17, 2005 Acquired Organization: Epimmune Incorporated San Diego-based company with manufacturing facilities in Irvine, Calif. and Paris, France. Acquiring Organization: IDM Pharma …See details»
Epimmune Incorporated - Tech Stack, Apps, Patents & Trademarks …
Organization. Epimmune Incorporated . Connect to CRM . Save . Summary. People. Technology. Signals & News. Patents and Trademarks by IPqwery. Edit Patents and Trademarks by …See details»
Epimmune Inc. - BioCentury Company Profiles - BCIQ
Jul 16, 2012 Epimmune Inc. - BioCentury Company Profiles for the biopharma industrySee details»
EP-1043 - Drug Targets, Indications, Patents - Synapse - Patsnap
Originator Organization. Onyvax Ltd. Active Organization-Inactive Organization. Onyvax Ltd. Pharmexa-Epimmune, Inc. National Institute of Allergy & Infectious Diseases. Drug Highest …See details»
CY-1747 - Drug Targets, Indications, Patents - Synapse
CY-1747, Initially developed by Epimmune, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Cardiovascular Diseases.See details»
Epimmune and IDM to merge - Pharmaceutical Business review
The two companies have signed a definitive agreement under which Epimmune will combine with privately-held IDM in an all-stock transaction. By combining, Epimmune and IDM expect to …See details»
Epimmune and Anosys announce merger agreement - bionity.com
May 14, 2003 Epimmune Inc. and Anosys Inc. today announced that they have entered into a definitive merger agreement under which Epimmune will merge with privately-held Anosys in a …See details»
EPIMMUNE AND MERCK ENTER INTO AGREEMENT
May 2, 2003 Epimmune Inc. today announced that it had entered into an Agreement with Merck & Co., Inc. under which Merck will evaluate select Epimmune epitopes in connection with …See details»
Epimmune and IDM to merge - PharmaTimes
Mar 17, 2005 From Epimmune are compounds including EP-2101, which is undergoing Phase II testing for non-small cell lung cancer. On a pro forma basis, the merger firm had net cash of …See details»
Pharmexa A/S - Drug pipelines, Patents, Clinical trials - Synapse
Epimmune, Inc. [+2] EUCTR2006-002211-26-ES / Unknown status Not Applicable. ... The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted …See details»